Metzner, T.; Leitner, D.R.; Mellitzer, K.; Beck, A.; Sourij, H.; Stojakovic, T.; Reishofer, G.; März, W.; Landmesser, U.; Scharnagl, H.;
et al. Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study. Biomedicines 2022, 10, 193.
https://doi.org/10.3390/biomedicines10010193
AMA Style
Metzner T, Leitner DR, Mellitzer K, Beck A, Sourij H, Stojakovic T, Reishofer G, März W, Landmesser U, Scharnagl H,
et al. Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study. Biomedicines. 2022; 10(1):193.
https://doi.org/10.3390/biomedicines10010193
Chicago/Turabian Style
Metzner, Thomas, Deborah R. Leitner, Karin Mellitzer, Andrea Beck, Harald Sourij, Tatjana Stojakovic, Gernot Reishofer, Winfried März, Ulf Landmesser, Hubert Scharnagl,
and et al. 2022. "Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study" Biomedicines 10, no. 1: 193.
https://doi.org/10.3390/biomedicines10010193
APA Style
Metzner, T., Leitner, D. R., Mellitzer, K., Beck, A., Sourij, H., Stojakovic, T., Reishofer, G., März, W., Landmesser, U., Scharnagl, H., Toplak, H., & Silbernagel, G.
(2022). Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study. Biomedicines, 10(1), 193.
https://doi.org/10.3390/biomedicines10010193